SCHEMBL7899170

SCHEMBL7899170

CC(=O)NC1CCN(c2ccc(OCc3ccccc3)cc2)CC1.c1cc2ccc1-2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.56
ACACB O00763 2/20 0.55
ME3 Q16798 1/20 0.55
MAPT P10636 4/20 0.53
KDM4E B2RXH2 1/20 0.53
RORC P51449 1/20 0.52
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
DRD2 P14416 1/20 0.48
DRD3 P35462 1/20 0.48
SLC6A5 Q9Y345 2/20 0.48
MAOB P27338 2/20 0.48
MAOA P21397 1/20 0.48
RAB9A P51151 1/20 0.47
CKS1B P61024 1/20 0.47
SKP1 P63208 1/20 0.47
SKP2 Q13309 1/20 0.47
MCHR1 Q99705 1/20 0.47
MRGPRX4 Q96LA9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20887692 0.90 ACACB (0.61) LTA4HACACBME3MAPTKDM4E
SCHEMBL20887689 0.90 ACACB (0.61) LTA4HACACBME3MAPTKDM4E
SCHEMBL7898002 0.85 ME3 (0.76) ME3MAPTALDH1A1LMNAHTT
SCHEMBL20887739 0.85 MAOB (0.54) LTA4HACACBMAPTKDM4EALDH1A1
SCHEMBL12321963 0.83 CKS1B (0.53) ACACBME3MAPTKDM4EALDH1A1
SCHEMBL2883836 0.81 DRD2 (0.53) LTA4HME3MAPTKDM4ERORC
SCHEMBL7899165 0.81 ME3 (0.58) LTA4HME3MAPTALDH1A1LMNA
SCHEMBL19658840 0.79 DRD2 (0.65) LTA4HME3RORCDRD2DRD3
SCHEMBL17888549 0.77 RAB9A (0.68) LTA4HACACBMAPTKDM4EALDH1A1
SCHEMBL32665123 0.77 ACACB (0.52) ACACBME3SLC6A5CKS1BSKP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1141936-C Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system - 2004-03-17 CN disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
CN-1248439-A Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system HOFFMAN LA ROCHE & CO AKTEINGE (DE) 2000-03-29 CN disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed